Abstract
O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET), a fluorine-18 labeled analogue of tyrosine, has been synthesized and biologically evaluated in tumor-bearing mice. The whole synthesis procedure is completed within 50 min. The radiochemical yield is about 40% (no decay corrected) and radiochemical purity more than 97% after simplified solid phase extraction. [18F]FET shows rapid, high uptake and long retention in the tumor as well as low uptake in the brain. The ratios of tumor-to-muscle (T/M) and tumor-to-blood (T/B) of [18F]FET are similar to those of [18F]FDG, but the ratios of tumor-to-brain (T/Br) are 2–3 times higher than that of [18F]FDG. Autoradiography of [18F]FET demonstrates a remarkable accumulation in melanoma with high contrast. It appears to be a probable competitive candidate for melanoma imaging with PET.
Similar content being viewed by others
References
Hustinx R, Benard F, Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med, 2002, 32(1): 35–46
Gambhir S S, Czernin J, Schwimmer J, Silverman D H S, Coleman R E, Phelps M E. A tabulated summary of the FDG PET literature. J Nucl Med, 2001, 42(Suppl): 1S–93S
Heiss P, Mayer S, Herz M, Wester H J, Schwaiger M, Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kineticsof O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med, 1999, 40(8): 1367–1373
Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med, 1994, 35(1): 104–112
Shreve P D, Anzai Y, Wahl R L. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics, 1999, 19(1): 61–77
Brown R S, Leung J Y, Kison P V, Zasadny K R, Flint A, Wahl R L. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med, 1999, 40(4): 556–565
Marom E M, Aloia T A, Moore M B, Hara M, Herndon II J E, Harpole Jr D H. Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer, 2001, 33(2): 99–107
Jager P L, Vaalburg W, Pruim J, de Vries E G E, Langen K J, Riers D A. Radiolabeled amino acids: Basic aspects and clinical applications in oncology. J Nucl Med, 2001, 42(3): 432–45
Laverman P, Boerman O C, Corstens F H M, et al. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med, 2002, 29: 681–690
Wester H J, Herz M, Weber W, Schwaiger M, Stocklin G. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med, 1999, 40(1): 205–212
Coenen H H, Kling P, Stocklin G. Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis. J Nucl Med, 1989, 30(8): 1367–1372
Wienhard K, Herholz K, Coenen H H, Rudolf J, Kling P, Stocklin G, Heiss W D. Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. J Nucl Med, 1991, 32(9): 1338–1346
Inoue T, Tomiyoshi K, Higuichi T, Ahmed K, Sarwar M, Aoyagi K, Amano S, Alyafei S, Zhang H, Endo K. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: A potential tumordetecting agent. J Nucl Med, 1998, 39(4): 663–667
Inoue T, Shibasaki T, Oriuchi N, Aoyagi K, Tomiyoshi K, Amano S, Mikuni M, Ida I, Aoki J, Endo K. 18F alpha-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med, 1999, 40(3): 399–405
Tang G H, Wang M F, Tang X L, Luo L, Gan M Q. Fully automated synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine. J Nucl Radiochem (in Chinese), 2003, 25(1): 44–48
Hamacher K, Coenen H H. Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine. Appl Radiat Isotopes, 2002, 57(6): 853–856
Wang H E, Wu S Y, Chang C W, Liu R S, Hwang L C, Lee T W, Chen J C, Hwang J J. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model. Nucl Med Biol, 2005, 32(4): 367–375
Pöpperl G, Götz C, Rachinger W, Gildehaus F J, Tonn J C, Tatsch K. Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging, 2004, 31(11): 1464–1470
Weber W A, Wester H J, Grosu A L, Herz M, Dzewas B, Feldmann H J, Molls M, Stöcklin G, Schwaiger M. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med, 2000, 27(5): 542–549
Weckesser M, Langen K J, Rickert C H, Kloska S, Straeter R, Hamacher K, Kurlemann G, Wassmann H, Coenen H H, Schober O. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging, 2005, 32(4): 422–429
Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, Herzog H, Bröer S, Coenen H H, Langen K J. PET with O-(2-18F-Fluoroethyl)-L-tyrosine in peripheral tumors: First clinical results. J Nucl Med, 2005, 46(3): 411–416
Moreau M F, Papon J, Labarre P, Moins N, Borel M, Bayle M, Bouchon B, Madelmont J C. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives. Nucl Med Biol, 2005, 32(4): 377–384
Moon B S, Kim S W, Lee T S, Ahn S H, Lee K C, An G I, Yang S D, Chi D Y, Choi C W, Lim S M, Chun K S. Synthesis of O-(3-[18F]Fluoropropyl)-L-tyrosine (L-[18F]FPT) and its biological evaluation in 9L tumor bearing rat. B Kor Chem Soc, 2005, 26(1): 91–96
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Knowledge Innovation Project of Chinese Academy of Sciences (No. KJCX1-SW-08) and the National Natural Science Foundation of China (Grant No. 30371634)
Rights and permissions
About this article
Cite this article
Wang, M., Yin, D., Li, S. et al. Synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine and its biological evaluation in B16 melanoma-bearing mice as PET tracer for tumor imaging. SCI CHINA SER B 50, 276–283 (2007). https://doi.org/10.1007/s11426-007-0023-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11426-007-0023-y